Company intelligence / Profile preview

NeuroOne

Eden Prairie, Minnesota, United Statesnmtc1.com ↗

Ownership: Public · NMTC
Development stage: Commercial

Overview

NeuroOne has developed FDA-cleared thin film electrodes that are commercially available and used in leading U.S. medical centers for the diagnosis and treatment of epilepsy. The electrodes provide real-time, high-resolution brain signal recordings as well as the ability to stimulate brain tissue during neurosurgical procedures. The company is partnered with Zimmer Biomet to expand commercialization efforts.

Therapeutic areas: Neurology
Modalities: DeviceNeuromodulation deviceThin film electrode technology
Industry: Implantable Medical Devices

Partnerships

Zimmer Biomet

Financials

Market cap: $14.7M
Total revenue: $2M
Enterprise value: $12.7M

Beyond the preview

Go deeper on NeuroOne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroOne.

Explore the full profile